Seasonal Allergic Rhinitis and Driving Ability
Phase 4
Terminated
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Other: 1 week of treatment discontinuation
- Registration Number
- NCT00223587
- Lead Sponsor
- Utrecht Institute for Pharmaceutical Sciences
- Brief Summary
On-the-road driving performance of untreated seasonal allergic rhinitis patients during the allergic season (exposed) is compared to driving performance outside the allergic season (in winter, not-exposed).
- Detailed Description
This study was set-up to examine whether untreated seasonal allergic rhinitis has an effect on driving ability. In addition to the driving tests, patients perform a memory test in the laboratory.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
- outpatients with seasonal allergic rhinitis
- a valid driver's licence
- written informed consent
- a T5SS score >8 during the allergic season and <3 in winter
Exclusion Criteria
- use of medication or medical conditions that are known to affect driving ability
- associated ENT disease or asthma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description A 1 week of treatment discontinuation 1 week of treatment discontinuation
- Primary Outcome Measures
Name Time Method Driving test: Standard Deviation of Lateral Position (SDLP, cm); i.e. the weaving of the car [after 1 week of treatment discontinuation] allergic season and winter
- Secondary Outcome Measures
Name Time Method Other driving test parameters: standard deviation of speed, mean speed, meal lateral position [after 1 week of treatment discontinuation] allergic season and winter Memory test: immediate and delayed recall, delayed recognition [after 1 week of treatment discontinuation] allergic season and winter
Trial Locations
- Locations (1)
Utrecht Institute for Pharmaceutical Sciences
🇳🇱Utrecht, Netherlands